Psychopharm in 2019: Your Ultimate Guide
In this podcast episode, we review the major FDA approvals in psychopharmacology for 2019. We explore brexanolone, bremelanotide, the asenapine skin patch, esketamine, cariprazine, and lumateperone. Download a PDF of this interview here Become a premium member of the Psychopharmacology Institute
